Skip to the page

Data / Drug companies / Levonorgestrel and ethinyl estradiol

Levonorgestrel and ethinyl estradiol: 19 companies and 42 products in the FDA NDC directory

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Levonorgestrel and ethinyl estradiol is listed in the FDA National Drug Code Directory by 19 companies, with 42 products in commercial distribution. 39 of the products (92.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are kit; tablet, and the newest product started marketing on February 13, 2026.

The request: Get every company that lists levonorgestrel and ethinyl estradiol in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
19
Products
42
Generic (ANDA) products
39 (92.9%)
Application numbers
31
Routes
Oral
Brand names
Levonest, Lutera, Aubra Eq, Aviane, Kurvelo, Altavera, Lessina, Dolishale
openFDA record search
api.fda.gov

Companies that list levonorgestrel and ethinyl estradiol

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Lupin Pharmaceuticals, Inc.6kitGeneric drugs (ANDA)February 7, 2021
A-S Medication Solutions3kitGeneric drugs (ANDA)February 7, 2021
Aurobindo Pharma Limited3kitGeneric drugs (ANDA)June 29, 2018
Bryant Ranch Prepack3kitGeneric drugs (ANDA)March 15, 2018
Glenmark Pharmaceuticals Inc., USA3kit; tabletGeneric drugs (ANDA)June 12, 2015
Mayne Pharma Inc.3kitGeneric drugs (ANDA)August 3, 2016
NorthStar Rx LLC3kitGeneric drugs (ANDA)August 1, 2015
Teva Pharmaceuticals USA, Inc.3kitGeneric drugs (ANDA)June 27, 2002
Xiromed, LLC3kitGeneric drugs (ANDA)September 1, 2022
Afaxys Pharma, LLC2kitGeneric drugs (ANDA)November 14, 2016
Naari Pte Limited2kitGeneric drugs (ANDA)March 31, 2024
Acella Pharmaceuticals, LLC1kitNew drug applications (NDA)August 21, 2023
Avion Pharmaceuticals, LLC1kitNew drug applications (NDA)April 10, 2018
Dr. Reddy's Laboratories Inc.1kitGeneric drugs (ANDA)February 13, 2026
Exeltis USA, Inc.1kitNew drug applications (NDA)October 26, 2020
Ingenus Pharmaceuticals, LLC1tabletGeneric drugs (ANDA)January 3, 2021
Mylan Pharmaceuticals Inc.1kitGeneric drugs (ANDA)June 26, 2014
Proficient Rx LP1kitGeneric drugs (ANDA)April 2, 2001
Teva Pharmaceuticals, Inc.1tabletGeneric drugs (ANDA)March 1, 2023

Dosage forms

Dosage formProductsShare
Kit3992.9%
Tablet37.1%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3992.9%
New drug applications (NDA)37.1%

Pharmacologic classes

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.